Abvc Biopharma

ABVCNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$27.085 M

$1.02 +0.00%

Close of 7 Aug 2026

Revenue

$509.6K

#3555 by revenue

Earnings

-$7.91M

Loss-making

Shares outstanding

25,440,407

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#379Universe PharmaceuticalsUPC$27.9M
#380BioXcel TherapeuticsBTAI$27.8M
#381Abvc BiopharmaABVC$27.1M
#382Actuate TherapeuticsACTU$26.4M
#383Aytu BiopharmaAYTU$25.3M

Where these numbers come from

Share counts and financials for Abvc Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.